Roy Brown

CONFLICT OF INTEREST STATEMENT A.B. received research funding from Novo Nordisk for the purchase of a research device. R.E. and A.B. have been invited to give lectures sponsored by Novo Nordisk and Eli Lilly, companies that manufacture and market treatments for obesity. These entities had no role in the writing of this manuscript and placed no restrictions on its submission. All other authors declare no conflicts of interest. REFERENCES 1, , .

Conflicts of Interest The authors declare no conflicts of interest. References , , , and . 2017. “Family Quality of Life in The Democratic Republic of the Congo.” Journal of Policy and Practice in Intellectual Disabilities 14: 78–86. https://doi.org/10.1111/jppi.12189. , and . 1976. Social Indicators of Well-Being: America's Perception of Life Quality. Plenum. https://doi.org/10.1007/978–1–4684-2253-5. , , , and . 2023.

1 INTRODUCTION Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of mortality worldwide, accounting for 17.9 million people dying from cardiovascular diseases in 2019, representing 32% of all global deaths.1 These deaths and related ASCVD events like myocardial infarction (MI) and stroke, result from the accumulation of atherosclerotic plaque in the artery walls.